A novel quantitative chick embryo assay as an angiogenesis model using digital image analysis

Anticancer Research

Volumn 24, Issue 3 A, 2004, Pages 1545-1551

  Peifer, Christian ^a   Dannhardt, Gerd ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Angiogenesis inhibition; Antiangiogenic compounds; Chick embryo assay; Digital image analysis

Indexed keywords

CAPTOPRIL; THALIDOMIDE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; BLASTODERM; CHICK EMBRYO; CONTROLLED STUDY; DRUG STRUCTURE; EMBRYO; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMAGE ANALYSIS; METASTASIS; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH;

ALLANTOIS; ANGIOGENESIS INHIBITORS; ANIMALS; CAPTOPRIL; CHICK EMBRYO; CHORION; DRUG SCREENING ASSAYS, ANTITUMOR; IMAGE PROCESSING, COMPUTER-ASSISTED; NEOVASCULARIZATION, PHYSIOLOGIC; REPRODUCIBILITY OF RESULTS; THALIDOMIDE;

EID: 3242724199     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Carmeliet P and Jain RK: Angiogenesis in cancer and other diseases. Nature 407: 249-257, 2000.
2. Fan TD and Brem S: Angiosuppression. In: The Search for New Anti-cancer Drugs (Waring and Ponder eds.) Dordrecht Kluwer Academic press 1992, pp 185-229.
3. Dudek AZ, Pawlak WZ and Kirstein MN: Molecular targets in the inhibition of angiogenesis. Expert Opin Ther Targets 7(4): 527-541, 2003.
4. Yancopoulus GD, Davis S, Gale NW, Rudge JS, Wiegand SJ and Holash J: Vascular-specific growth factors and blood vessel formation. Nature 407: 242-248, 2000.
5. Auerbach R, Lewis R, Shinners B, Kubai L and Aktar N: Angiogenesis assays: A critical overview. Clin Chem 49: 32-40, 2003.
6. Lüpke NP: The hen's egg test (HET)- an alternative toxicity test. Br J Dermat 115: 133-135, 1986.
7. Schöffl H, Schulte-Hermann R and Tritthart HA (eds): Möglichkeiten und Grenzen der Reduktion von Tierversuchen. Springer Verlag Wien, New York, 1992.
8. Spielmann H, Liebsch M, Moldenhauer F, Holzhutter HG, Bagley DM, Lipmann JM, Pape WJ, Miltenburger H and De Siva O: IRAG working group 2. CAM-based assays. Interagency regulatory alternatives group. Food Chem Toxicol 35(1): 39-66, 1997.
9. Ribatti D, Nico B, Vacca A, Roncali L, Burri PH and Djonov V: Chorioallantoic membrane capillary bed: a useful target for studying angiogenesis and anti-angiogenesis in vivo. Anat Rec 264: 317-324, 2001.
10. Leene W, Duyzings MJM and von Steeg C: Lymphoid stem cell identification in the developing thymus and bursa of Fabricius of the chick. Z Zellforsch 136: 521-533, 1973.
11. Ribatti D, Vacca A, Roncali L and Dammacco F: The chick embryo chorioallantoic membrane as a model for in vivo research on angiogenesis. Int J Dev Biol 40: 1189-1197, 1996.
12. Hazel SJ: A novel early chorioallantoic membrane assay demonstrates quantitative and qualitative changes caused by antiangiogenic substances. J Lab Clin Med 141(3): 217-228, 2003.
13. Hoffman R, Paper DH, Donaldson J and Vogl H: Inhibition of angiogenesis and murine tumour growth by laminarin sulphate. Br J Cancer 73: 1183-1186, 1996.
14. Richardson M and Singh G: Observations on the use of the avian chorioallantoic membrane (CAM) model in investigations into angiogenesis. Curr Drug Targets - Cardiovas Haematol Disorders 3: 155-185, 2003.
15. Jakob W and Voss K: Utilization of image analysis for the quantification of vascular responses in the chick chorioallantoic membrane. Exp Path 26: 93-99, 1984.
16. Hamburger V and Hamilton HL: A series of normal stages in the development of the chick embryo. J Morphol 88: 49-92, 1951.
17. Sharma S, Ghoddoussi M, Kellof GJ, Steel VE and Kopelovich L: A quantitative angiogenesis model for efficacy testing of chemopreventive agents. Anticancer Res 21: 3829-3838, 2001.
18. Calabrese L and Fleischer AB: Thalidomide: Current and potential clinical applications. Am J Med 108: 487-495, 2000.
19. Vogt B and Frey FJ: Inhibition of angiogenesis in Kaposi's Sarcoma by captopril. Lancet 349(9059): 1148, 1997.
20. Scharnbacher K: Statistik im Betrieb, Gabler 12. Auflage: p. 216, 1999.
21. Lanot R: Formation of the early vascular network in the chick embryo, microscopical aspects. Arch Biol (Bruxelles) 91: 423-438, 1980.
22. Aitkenhead M, Christ B, Eichmann A, Feucht M, Wilson DJ and Wilting J: Paracrine and autocrine regulation of vascular endothelial growth factor during tissue differentiation in the quail. Devel Dynamics 212: 1-13, 1998.
23. Vico PG, Kyriacos S, Heymans O, Louryan S and Cartilier L: Dynamic study of the extraembryonic vascular network of the chick embryo by fractal analysis. J Ther Biol 195: 525-532, 1998.
24. Clement B and Mladek C: Biotransformation processes in fertile hen's eggs. Metabolic transformation of 7-Ethoxycoumarin. Arch Phar Weinheim 50(3): 207-210, 1995.
25. Jakob W, Jentzsch KD, Mauersberger B and Heder G: The chick embryo chorioallantoic membrane as a bioassay for angiogenesis factors: Reactions induced by carrier materials. Exp Path 15: 241-249, 1978.
26. Fanelli M, Sarmiento R, Gattuso D, Carillio G, Capaccetti B, Vacca A, Roccaro AM and Gasparini G: Thalidomide: a new anticancer drug? Expert Opin Investig Drugs 12(7): 1211-1225, 2003.
27. D'Amato RJ, Loughnan MS, Flynn E and Folkmann J: Thalidomide is a inhibitor of angiogenesis. Proc Natl Acad Sci USA 91: 4082-4085, 1994.
28. Yoshiji H, Kuryiama S and Fukui H: Angiotensin-I-converting enzyme inhibitors may be an alternative anti-angiogenic strategy in the treatment of liver fibrosis and hepatocellular carcinoma. Possible role of vascular endothelial growth factor. Tumour Biol 23(6): 348-356, 2002.
29. Ferrara N, Gerber HP and LeCouter J: The biology of VEGF and its receptors. Nat Med 9(6): 669-676, 2003.